Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R *** > Treatment > Co: USA. G. Brand Idelalisib Tab.>

---

Co: USA. G. Brand Idelalisib Tab.>'s subsections
(*) EU Approval Date: 2014. 09.18.
(*) USA>Approval Date: 2014. 07.23
>Worsens>Treat.>2 Prior Medicines
Company
Mechanism: PI3K Inhibition
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

Co: USA. G. Brand Idelalisib Tab.>'s products
This section has no products